Olga Dakhova

Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

Nabil Ahmed, Vita S. Brawley, Meenakshi Hegde et al. · Journal of Clinical Oncology · 2015 · 959 citations · Full text

Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15

Yang Xu, Ming Zhang, Carlos A. Ramos et al. · Blood · 2014 · 710 citations

CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma

Andras Heczey, Chrystal U. Louis, Barbara Savoldo et al. · Molecular Therapy · 2017 · 511 citations · Full text

Radiation Oncology, Cell Therapy, Cancer Immunosurveillance +6

Clinical and immunological responses after CD30-specific chimeric antigen receptor–redirected lymphocytes

Carlos A. Ramos, Brandon Ballard, Huimin Zhang et al. · Journal of Clinical Investigation · 2017 · 365 citations · Full text

In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin’s Lymphomas

Carlos A. Ramos, Rayne H. Rouce, Catherine Robertson et al. · Molecular Therapy · 2018 · 281 citations · Full text

Lymphocyte Development, T-regulatory Cell, Immunology +18